Megan M O'donovan, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 26 N Main St, Shickshinny, PA 18655 Phone: 570-542-4141 Fax: 570-542-2580 |
Cheryl Bunk, Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 237 Shickshinny Lake Rd, Shickshinny, PA 18655 Phone: 570-344-9266 |
Colleen Reynolds, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 26 N Main St, Shickshinny Health Center, Shickshinny, PA 18655 Phone: 570-542-4141 Fax: 570-542-2580 |
News Archive
The National Community Pharmacists Association is pressuring Medicare officials to delay a regulation that they say will drive up labor costs for drug stores and increase the potential for dispensing errors. The proposed rule is expected to be finalized and take effect on Jan. 1, 2012.
A Los Angeles ordinance designed to curb obesity in low-income areas by restricting the opening of new fast-food restaurants has failed to reduce fast-food consumption or reduce obesity rates in the targeted neighborhoods, according to a new RAND Corporation study.
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
Today, Siemens Healthineers Laboratory Diagnostics business launched the Sysmex CS-2500 System—a mid-volume, fully-automated coagulation analyzer with smartly-designed PSI technology—in major markets including the U.S. Together with Lab Alliance of Central New York, the first U.S. customer to install the high-volume Sysmex CS-5100 System, the company celebrated the availability of its new Sysmex CS Hemostasis System portfolio in the U.S.
GlaxoSmithKline plc (GSK) and XenoPort, Inc. announced today that the United States (US) Food and Drug Administration (FDA) has approved Horizant (gabapentin enacarbil) Extended-Release Tablets for the management of postherpetic neuralgia (PHN) in adults.
› Verified 7 days ago